Arthritis · Fort Worth, TX
Arthritis studies in Fort Worth, TX
4 recruiting studies have a site in Fort Worth.
4 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Fort Worth, TX + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Fort Worth, TX + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Janssen Research & Development, LLC
- Location
- Fort Worth, TX + 5 other US sites
- Eligibility basics
- Ages 3+
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Eli Lilly and Company
- Location
- Fort Worth, TX + 35 other US sites
- Eligibility basics
- Ages 40+
Who these studies look for
Most require a confirmed diagnosis, often with X-rays or blood tests, and set rules for pain medicines during the study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.